Galecto Inc. (GLTO): Price and Financial Metrics
GLTO Price/Volume Stats
| Current price | $4.70 | 52-week high | $23.50 |
| Prev. close | $4.66 | 52-week low | $4.40 |
| Day low | $4.66 | Volume | 16,800 |
| Day high | $4.86 | Avg. volume | 16,891 |
| 50-day MA | $6.25 | Dividend yield | N/A |
| 200-day MA | $12.56 | Market Cap | 6.19M |
GLTO Stock Price Chart Interactive Chart >
Galecto Inc. (GLTO) Company Bio
Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.
GLTO Price Returns
| 1-mo | -19.59% |
| 3-mo | -64.56% |
| 6-mo | -64.18% |
| 1-year | -70.41% |
| 3-year | -94.16% |
| 5-year | N/A |
| YTD | -73.89% |
| 2023 | -37.39% |
| 2022 | -62.05% |
| 2021 | -75.78% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...